Victoria Balannik - Profile and Investment Details

Investor Profile

Victoria Balannik is a Angel Group based in Ra'anana, Tel Aviv District, Israel with a diverse investment portfolio that includes companies such as CuResponse, InfluMedix, Inc., Karius, AbSci, CartiHeal, Zebra Medical Vision, Mammoth Biosciences, DayTwo, AtaCor Medical, MiNA Therapeutics, Ibex Medical Analytics, NanoGhosts, BiolineRx, Theranica, Scipher Medicine, Seer, aMoon Fund, Mobilion Systems, Nobio, MDClone, Medial EarlySign, SOPHiA GENETICS, Vocalis Health, Viracta Therapeutics, Ayala Pharmaceuticals, Igentify, Nectin Therapeutics, Apos Therapy, . Over time, Victoria Balannik has demonstrated experience in supporting a range of businesses across various sectors.

While it is not publicly confirmed whether Victoria Balannik is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.

Startups and entrepreneurs operating in sectors related to Health Care, Research and Development, Hospitals, Genetics, Patient Management, Alternative Medicine, Wellness, Immunotherapy, Rare Diseases, Life Science, Artificial Intelligence (AI), Analytics, Bioinformatics, Biotechnology, Drug Development, Genomics, Precision Medicine, Clinical Trials, Research, Personalized Medicine, Health Diagnostics, Medical, Big Data, Information Technology, B2B, Therapeutics, Machine Learning, Pharmaceuticals, Oncology may find it worthwhile to explore potential connections with Victoria Balannik, as their portfolio suggests a familiarity and interest in this area.

Understanding Victoria Balannik’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.